CRAd-S-pk7

AXP000052.1 · Oncolytic virus

Platform
adenovirus (Ad5, survivin promoter-driven E1A, polylysine (pk7) fiber)
Originator
Northwestern University
Sponsor
Northwestern University

Names

NameTypeSource
CRAd-S-pk7preferred name, codecurator, ncit
NSC-CRAd-S-pk7synonymncit
NSC-CRAd-Survivin-pk7synonymctgov

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 (CRAd-S-pk7)
Replication
conditionally replicating
Modifications
survivin promoter drives E1A; polylysine (pk7) fiber modification
Route
intracerebral
Carrier
HB1.F3.CD neural stem cells
Source
evidence

Cross-references

NCI Thesaurus
C135612

Approvals

No regulatory approval recorded.

Clinical trials (3)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06169280Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade GliomaActive not recruitingPhase 12025-06-272029-12-3120Glioma, Malignant; New Diagnosis Tumor
NCT05139056Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade GliomasRecruitingPhase 12023-05-022028-02-0736Currently Only Enrolling Glioblastoma Patients at First Recurrence
NCT03072134Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant GliomaCompletedPhase 12017-04-242020-04-0612Anaplastic Astrocytoma; Anaplastic Oligoastrocytoma; Anaplastic Oligodendroglioma; Astrocytoma, Grade III; Astrocytoma, Grade IV; Brain Cancer; Glioblastoma Multiforme; Glioma

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 34214495Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.The Lancet. Oncology2021cited by trial NCT03072134

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 42179969Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies.Molecular therapy. Oncology2026name in title: CRAd-S-pk7
PMID 42741068Treatment sequence of stem cell delivered heterologous oncolytic virus impact on tumor microenvironment in immunocompetent ovarian cancer model.Frontiers in immunology2026name in abstract: NSC-CRAd-S-pk7
PMID 33272983Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.Clinical cancer research : an official journal of the American Association for Cancer Research2021name in abstract: CRAd-S-pk7
PMID 34944938Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of Glioblastoma.Cancers2021name in abstract: NSC-CRAd-S-pk7
PMID 30719498Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer.Molecular therapy oncolytics2019name in abstract: CRAd-S-pk7
PMID 27184224Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters.Journal of translational medicine2016name in title: CRAd-S-pk7
PMID 25525033Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.Cancer gene therapy2015name in abstract: NSC-CRAd-S-pk7
PMID 22673390Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.Gene therapy2013name in abstract: CRAd-S-pk7
PMID 23883863N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.Molecular therapy : the journal of the American Society of Gene Therapy2013name in abstract: CRAd-S-pk7
PMID 23926209The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.Stem cells translational medicine2013name in abstract: CRAd-S-pk7
PMID 22555507Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.Cancer gene therapy2012name in abstract: CRAd-S-pk7
PMID 21629227Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.Molecular therapy : the journal of the American Society of Gene Therapy2011name in abstract: CRAd-S-pk7
PMID 20573677A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect.Human reproduction (Oxford, England)2010name in title: CRAd-S-pk7
PMID 19078993Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.Gene therapy2009name in abstract: CRAd-S-pk7
PMID 19277041Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.British journal of cancer2009name in abstract: CRAd-S-pk7
PMID 17630837Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.Human gene therapy2007name in abstract: CRAd-S-pk7
PMID 17016667Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma.International journal of oncology2006name in abstract: CRAd-S-pk7

NIH grants

ProjectTitleOrganisationPIYearsLinked by
P50CA221747Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant GliomaNORTHWESTERN UNIVERSITYLESNIAK, MACIEJ S2018–2022name in abstract: CRAd-S-pk7
R01CA122930Conditionally Replicative Adenoviral Vectors for Malignant GliomaUNIVERSITY OF CHICAGOLESNIAK, MACIEJ S2008–2012name in abstract: CRAd-S-pk7

Notes

Delivered in HB1.F3.CD neural stem cells (NSC-CRAd-S-pk7) into the resection cavity in newly diagnosed malignant glioma, NCT03072134.

How to cite

CRAd-S-pk7 (AXP000052.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000052.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.